| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/07/2003 | WO2003064454A1 Fap-activated anti-tumor compounds |
| 08/07/2003 | WO2003064449A2 Bioactive keratin peptides |
| 08/07/2003 | WO2003064447A2 Immune-modulating peptide |
| 08/07/2003 | WO2003064416A1 Heterocyclic tripeptides as hepatitis c inhibitors |
| 08/07/2003 | WO2003064403A1 Furanone derivatives |
| 08/07/2003 | WO2003063910A2 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER |
| 08/07/2003 | WO2003063760A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 08/07/2003 | WO2002055541A3 Peptides having inhibiting activity on the production of nitric oxide |
| 08/07/2003 | US20030149262 Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
| 08/07/2003 | US20030149049 Small-molecule inhibitors of interleukin-2 |
| 08/07/2003 | US20030149022 Inhibiting beta -amyloid peptide release and/or its synthesis in a cell by administering deoxyamino acid compound |
| 08/07/2003 | US20030149004 Antibacterial activity |
| 08/07/2003 | US20030148961 Peptidyl ketones as inhibitors of DPIV |
| 08/07/2003 | US20030148933 Isolation of dehydrodidemnin B, a cyclic depsipeptide, from a tunicate of the Ascidiacea class; anticarcinogenic agents; antitumor agents; viricides; cytolysis; amidation of Didemnin A by 1-(pyruvyl)pyrridine-2-carboxylic acid |
| 08/07/2003 | CA2474871A1 Furanone derivatives |
| 08/07/2003 | CA2474723A1 Bioactive keratin peptides |
| 08/07/2003 | CA2473987A1 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 08/07/2003 | CA2472296A1 Fap-activated anti-tumor compounds |
| 08/06/2003 | EP1333094A2 Human telomerase catalytic subunit |
| 08/06/2003 | EP1333033A1 FAP-activated anti-tumor compounds |
| 08/06/2003 | EP1333024A1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 08/06/2003 | EP1189929B1 Factor viia inhibitors |
| 08/06/2003 | EP0804465B1 Novel elastase inhibitors |
| 08/06/2003 | CN1434803A Cyclic lactams as inhibitors os A-alpha protein production |
| 08/06/2003 | CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 08/06/2003 | CN1434025A Process for preparing 3-hydroxy-3-methylbutyrate (HMB) amino acid salt |
| 08/06/2003 | CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine |
| 08/06/2003 | CN1116813C Process for preparation of glyconitrogen and amphoteric nitrogen mixture |
| 08/05/2003 | US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. |
| 08/05/2003 | US6603002 Process and intermediates for growth hormone secretagogues |
| 08/05/2003 | US6602988 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects |
| 08/05/2003 | US6602982 Process for the preparation of regular glycopeptides |
| 08/05/2003 | US6602856 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
| 08/05/2003 | US6602817 Combination approach to chiral reagents or catalysts having amine or amino alcohol ligands |
| 08/05/2003 | CA2092062C Peptide synthesis process and novel synthesis intermediates |
| 08/01/2003 | CA2370400A1 Hepatitis c inhibitor tri-peptides |
| 08/01/2003 | CA2370396A1 Hepatitis c inhibitor tri-peptides |
| 08/01/2003 | CA2369970A1 Hepatitis c inhibitor tri-peptides |
| 07/31/2003 | WO2003062267A2 Enzyme substrates for the determination of activity of staphylococcus sp. extracellular protease |
| 07/31/2003 | WO2003062265A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 07/31/2003 | WO2003062261A2 Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use |
| 07/31/2003 | WO2003062247A2 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace) |
| 07/31/2003 | WO2003037269A3 Di-, tri,- and tetra-peptides having antiangiogenic activity |
| 07/31/2003 | WO2003002596A3 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 07/31/2003 | WO2002083729A3 Polypeptides derived from amyloid precursor peptide (app) and their uses |
| 07/31/2003 | US20030144342 alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 07/31/2003 | US20030144265 HIV protease inhibitors based on amino acid derivatives |
| 07/31/2003 | US20030144261 A cyclic peptide useful for treating eating disorder and diabetes |
| 07/31/2003 | US20030144183 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 07/31/2003 | US20030144175 Protease inhibitors |
| 07/31/2003 | US20030144165 For use in detergents and in baking |
| 07/31/2003 | US20030143570 A solid support comprising immobilized latent thiol groups, activating the thiol groups and reacting activated thiol groups with an affinity ligand having atleast an alpha-beta unsaturated carbonyl group, immobizing ligand on the support |
| 07/31/2003 | US20030143569 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 07/31/2003 | US20030143235 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis |
| 07/31/2003 | US20030143183 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 07/31/2003 | CA2473047A1 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace) |
| 07/31/2003 | CA2473032A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 07/30/2003 | EP1330470A1 Glutathione conjugates with distamycin derivatives having antitumor activity |
| 07/30/2003 | EP1330447A2 Peptides as met-ap2 inhibitors |
| 07/30/2003 | EP1330292A2 Radioactive member for use in brachytherapy and method of making |
| 07/30/2003 | EP0702696B1 Trifunctional antithrombin and antiplatelet peptides |
| 07/30/2003 | CN1433274A Sweeteners pariticularly for coffee and tea |
| 07/30/2003 | CN1116305C Peptide derivatives |
| 07/30/2003 | CN1116282C Bisulfate salt of HIV protease inhibitor |
| 07/30/2003 | CA2369711A1 Macrocyclic peptides active against the hepatitis c virus |
| 07/29/2003 | US6600015 Treatment or prevention of obesity. |
| 07/29/2003 | US6599894 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | CA2131982C Tripeptide antithrombotic agents |
| 07/24/2003 | WO2003059942A2 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 07/24/2003 | WO2003059939A1 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
| 07/24/2003 | WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof |
| 07/24/2003 | WO2003059881A2 Dna minor groove binding compounds |
| 07/24/2003 | WO2003059877A2 Novel affinity labels |
| 07/24/2003 | WO2003059436A2 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | WO2003059378A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2002094873A3 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 07/24/2003 | WO2002065853A3 Catalyst modification to enhance neotame production |
| 07/24/2003 | US20030139348 Animal growth regulators |
| 07/24/2003 | US20030138864 Comparing expression levels of genes or proteins in human tissue or cells from normal and tumor origin, selecting enzyme of which mRNA or protein levels in tumor tissue are higher by two-fold as compared to normal cells or tissue |
| 07/24/2003 | US20030138388 Artificial tanning |
| 07/24/2003 | CA2473447A1 Solid salts of benzazepine compounds and their use in the preparation of pharmaceutical compounds |
| 07/24/2003 | CA2472579A1 Hiv vaccine and method of use |
| 07/24/2003 | CA2471192A1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/24/2003 | CA2470503A1 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/23/2003 | EP1329457A2 Antipicornaviral compounds, their preparation and use |
| 07/23/2003 | EP1328658A2 Recombination modulators and methods for their production and use |
| 07/23/2003 | EP1328657A2 Process for detecting serine/threonine kinase activity |
| 07/23/2003 | EP1328539A1 Vegf peptides and their use for inhibiting angiogenesis |
| 07/23/2003 | EP1017711B1 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
| 07/23/2003 | EP0956033B1 Total synthesis of the amino hip analogue of didemnin a |
| 07/23/2003 | CN1432022A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/23/2003 | CN1431998A Growth hormone secretagogues |
| 07/23/2003 | CN1431995A Antipicornaviral compounds and compsns. their pharmaceutical uses, and materials for their synthesis |
| 07/23/2003 | CN1115145C Improving tolerability of pharmaceutically active beta-amino acids |
| 07/22/2003 | US6596867 Bone disorders |
| 07/22/2003 | US6596693 Dipeptide apoptosis inhibitors and the thereof |